{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:23:17Z","timestamp":1790716997971,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"This research was funded by Shire Human Genetic Therapies, Inc., a Takeda company, Lexington, MA, USA."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s12325-021-01649-2","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T13:02:55Z","timestamp":1615467775000},"page":"1946-1957","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Risk of Nephrolithiasis and Nephrocalcinosis in Patients with Chronic Hypoparathyroidism: A Retrospective Cohort Study"],"prefix":"10.1007","volume":"38","author":[{"given":"Markus","family":"Ketteler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira O.","family":"Gosmanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Signorovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Sherry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Rejnmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,11]]},"reference":[{"key":"1649_CR1","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1530\/EJE-18-0609","volume":"180","author":"AA Khan","year":"2019","unstructured":"Khan AA, Koch C, Van Uum SHM, et al. Standards of care for hypoparathyroidism in adults: a Canadian and international consensus. Eur J Endocrinol. 2019;180:P1\u201322.","journal-title":"Eur J Endocrinol"},{"key":"1649_CR2","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.ecl.2018.07.012","volume":"47","author":"M Babey","year":"2018","unstructured":"Babey M, Brandi ML, Shoback D. Conventional treatment of hypoparathyroidism. Endocrinol Metab Clin N Am. 2018;47:889\u2013900.","journal-title":"Endocrinol Metab Clin N Am"},{"key":"1649_CR3","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1002\/jbmr.2004","volume":"28","author":"J Powers","year":"2013","unstructured":"Powers J, Joy K, Ruscio A, Lagast H. Prevalence and incidence of hypoparathyroidism in the United States using a large claims database. J Bone Miner Res. 2013;28:2570\u20136.","journal-title":"J Bone Miner Res"},{"key":"1649_CR4","doi-asserted-by":"publisher","first-page":"671","DOI":"10.4158\/EP13328.OR","volume":"20","author":"N Hadker","year":"2014","unstructured":"Hadker N, Egan J, Sanders J, Lagast H, Clarke BL. Understanding the burden of illness associated with hypoparathyroidism reported among patients in the PARADOX study. Endocr Pract. 2014;20:671\u20139.","journal-title":"Endocr Pract"},{"key":"1649_CR5","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s00198-014-2677-6","volume":"25","author":"T Sikjaer","year":"2014","unstructured":"Sikjaer T, Rolighed L, Hess A, Fuglsang-Frederiksen A, Mosekilde L, Rejnmark L. Effects of PTH(1\u201384) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial. Osteoporos Int. 2014;25:1717\u201326.","journal-title":"Osteoporos Int"},{"key":"1649_CR6","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1210\/jc.2016-1477","volume":"101","author":"MC Astor","year":"2016","unstructured":"Astor MC, Lovas K, Debowska A, et al. Epidemiology and health-related quality of life in hypoparathyroidism in Norway. J Clin Endocrinol Metab. 2016;101:3045\u201353.","journal-title":"J Clin Endocrinol Metab"},{"key":"1649_CR7","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1002\/jbmr.2501","volume":"30","author":"L Underbjerg","year":"2015","unstructured":"Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. The epidemiology of nonsurgical hypoparathyroidism in Denmark: a nationwide case finding study. J Bone Miner Res. 2015;30:1738\u201344.","journal-title":"J Bone Miner Res"},{"key":"1649_CR8","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1210\/jc.2015-3909","volume":"101","author":"DM Shoback","year":"2016","unstructured":"Shoback DM, Bilezikian JP, Costa AG, et al. Presentation of hypoparathyroidism: etiologies and clinical features. J Clin Endocrinol Metab. 2016;101:2300\u201312.","journal-title":"J Clin Endocrinol Metab"},{"key":"1649_CR9","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3389\/fendo.2016.00172","volume":"7","author":"EG Abate","year":"2017","unstructured":"Abate EG, Clarke BL. Review of hypoparathyroidism. Front Endocrinol (Lausanne). 2017;7:172.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1649_CR10","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1210\/jc.2015-3907","volume":"101","author":"ML Brandi","year":"2016","unstructured":"Brandi ML, Bilezikian JP, Shoback D, et al. Management of hypoparathyroidism: summary statement and guidelines. J Clin Endocrinol Metab. 2016;101:2273\u201383.","journal-title":"J Clin Endocrinol Metab"},{"key":"1649_CR11","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1002\/jbmr.483","volume":"26","author":"JP Bilezikian","year":"2011","unstructured":"Bilezikian JP, Khan A, Potts JT Jr, et al. Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res. 2011;26:2317\u201337.","journal-title":"J Bone Miner Res"},{"key":"1649_CR12","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.1210\/jc.2012-1808","volume":"97","author":"DM Mitchell","year":"2012","unstructured":"Mitchell DM, Regan S, Cooley MR, et al. Long-term follow-up of patients with hypoparathyroidism. J Clin Endocrinol Metab. 2012;97:4507\u201314.","journal-title":"J Clin Endocrinol Metab"},{"key":"1649_CR13","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1002\/jbmr.1979","volume":"28","author":"L Underbjerg","year":"2013","unstructured":"Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J Bone Miner Res. 2013;28:2277\u201385.","journal-title":"J Bone Miner Res"},{"key":"1649_CR14","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/cen.13593","volume":"88","author":"L Underbjerg","year":"2018","unstructured":"Underbjerg L, Sikjaer T, Rejnmark L. Health-related quality of life in patients with nonsurgical hypoparathyroidism and pseudohypoparathyroidism. Clin Endocrinol (Oxf). 2018;88:838\u201347.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1649_CR15","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/jbmr.3368","volume":"33","author":"L Underbjerg","year":"2018","unstructured":"Underbjerg L, Sikjaer T, Rejnmark L. Long-term complications in patients with hypoparathyroidism evaluated by biochemical findings: a case-control study. J Bone Miner Res. 2018;33:822\u201331.","journal-title":"J Bone Miner Res"},{"key":"1649_CR16","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s40618-018-0857-5","volume":"41","author":"A Meola","year":"2018","unstructured":"Meola A, Vignali E, Matrone A, Cetani F, Marcocci C. Efficacy and safety of long-term management of patients with chronic post-surgical hypoparathyroidism. J Endocrinol Invest. 2018;41:1221\u20136.","journal-title":"J Endocrinol Invest"},{"key":"1649_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1530\/eje.0.1460215","volume":"146","author":"W Arlt","year":"2002","unstructured":"Arlt W, Fremerey C, Callies F, et al. Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin\u00a0D. Eur J Endocrinol. 2002;146:215\u201322.","journal-title":"Eur J Endocrinol"},{"key":"1649_CR18","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1210\/jc.2015-3910","volume":"101","author":"JP Bilezikian","year":"2016","unstructured":"Bilezikian JP, Brandi ML, Cusano NE, et al. Management of hypoparathyroidism: present and future. J Clin Endocrinol Metab. 2016;101:2313\u201324.","journal-title":"J Clin Endocrinol Metab"},{"key":"1649_CR19","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-15-0628","volume":"173","author":"J Bollerslev","year":"2015","unstructured":"Bollerslev J, Rejnmark L, Marcocci C, et al. European Society of Endocrinology clinical guideline: treatment of chronic hypoparathyroidism in adults. Eur J Endocrinol. 2015;173:G1\u2013120.","journal-title":"Eur J Endocrinol"},{"key":"1649_CR20","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1056\/NEJMcp0803050","volume":"359","author":"D Shoback","year":"2008","unstructured":"Shoback D. Hypoparathyroidism. N Engl J Med. 2008;359:391\u2013403.","journal-title":"N Engl J Med"},{"key":"1649_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4158\/EP10302.RA","volume":"17","author":"MI Khan","year":"2011","unstructured":"Khan MI, Waguespack SG, Hu MI. Medical management of postsurgical hypoparathyroidism. Endocr Pract. 2011;17:18\u201325.","journal-title":"Endocr Pract"},{"key":"1649_CR22","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fped.2018.00098","volume":"6","author":"A Weigert","year":"2018","unstructured":"Weigert A, Hoppe B. Nephrolithiasis and nephrocalcinosis in childhood-risk factor-related current and future treatment options. Front Pediatr. 2018;6:98.","journal-title":"Front Pediatr"},{"key":"1649_CR23","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1210\/jc.2012-2747","volume":"98","author":"AM Boyce","year":"2013","unstructured":"Boyce AM, Shawker TH, Hill SC, et al. Ultrasound is superior to computed tomography for assessment of medullary nephrocalcinosis in hypoparathyroidism. J Clin Endocrinol Metab. 2013;98:989\u201394.","journal-title":"J Clin Endocrinol Metab"},{"key":"1649_CR24","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1111\/j.1523-1755.2005.00599.x","volume":"68","author":"CS Saigal","year":"2005","unstructured":"Saigal CS, Joyce G, Timilsina AR, the Urologic Diseases in America Project. Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management? Kidney Int. 2005;68:1808\u201314.","journal-title":"Kidney Int"},{"key":"1649_CR25","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ekir.2016.12.007","volume":"2","author":"JM Taylor","year":"2017","unstructured":"Taylor JM, Kieneker LM, de Borst MH, et al. Urinary calcium excretion and risk of chronic kidney disease in the general population. Kidney Int Rep. 2017;2:366\u201379.","journal-title":"Kidney Int Rep"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01649-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-021-01649-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01649-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T19:10:37Z","timestamp":1616872237000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-021-01649-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,11]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1649"],"URL":"https:\/\/doi.org\/10.1007\/s12325-021-01649-2","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,11]]},"assertion":[{"value":"24 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}